In 2011,
clinical diagnostic criteria for Alzheimer’s disease dementia were revised, and
research guidelines for earlier stages of the disease were characterized to
reflect a deeper understanding of the disorder. Development of the new
guidelines was led by the National Institutes of Health and the Alzheimer’s
Association.
For more
information, visit the National Institute on Aging (NIA) and the Alzheimer's
Association.
Courtesy of the National Institutes on Aging and the Alzheimer’s
Association.
The DSHS Clinical Best
Practices for the Early Detection, Diagnosis, and Pharmaceutical and
Non-Pharmaceutical Treatment of Persons with Alzheimer’s Disease are under
review for updates.